Prevalence and early detection of oral fungal infection: A cross-sectional controlled study in a group of Swedish end-stage renal disease patients

References

• Koh, AY, Köhler, JR, Coggshall, KT, Van Rooijen, N, Pier, GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 2008; Feb 15;4:e35.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–63
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Fuursted K, Gahrn-Hansen B, Jensen IM, Knudsen JD, Lundgren B, et al. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 2005; 43: 4434–40
   PubMed Web of Science ®Google Scholar
• Kadir T, Pisiriciler R, Akyuz S, Yarat A, Emekli N, Ipbuker A. Mycological and cytological examination of oral candidal carriage in diabetic patients and non-diabetic control subjects: thorough analysis of local aetiologic and systemic factors. J Oral Rehabil 2002; 29: 452–7
   PubMed Web of Science ®Google Scholar
• Salonen L, Axell T, Hellden L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med 1990; 19: 170–6
   PubMed Web of Science ®Google Scholar
• Mitchell KG, Bradley JA, Ledingham IM, Hamilton DN. Candida colonization of the oral cavity. Surg Gynecol Obstet 1982; 154: 870–4
   PubMedGoogle Scholar
• Tapper-Jones LM, Aldred MJ, Walker DM, Hayes TM. Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 1981; 34: 706–11
   PubMed Web of Science ®Google Scholar
• Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685–702
   PubMed Web of Science ®Google Scholar
• Erkose G, Erturan Z. Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count. Mycoses 2007; 50: 485–90
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10(Suppl 1)48–66
   PubMed Web of Science ®Google Scholar
• Lim WH, Kireta S, Leedham E, Russ GR, Coates PT. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int 2007; 72: 1138–48
   PubMed Web of Science ®Google Scholar
• Scully C, Paes de Almeida O. Orofacial manifestations of the systemic mycoses. J Oral Pathol Med 1992; 21: 289–94
   PubMed Web of Science ®Google Scholar
• Jorda-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, Leon MA, et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007; 50: 302–10
   PubMed Web of Science ®Google Scholar
• Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006; 57: 628–38
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; 34: 857–63
   PubMed Web of Science ®Google Scholar
• Wenzel, RP, Gennings, C. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies [erratum appears in Clin Infect Dis 2005;41(Suppl 6):1694]. Clin Infect Dis 2005;41(Suppl 6):S389–93.
   PubMed Web of Science ®Google Scholar
• Wong PN, Lo KY, Tong GM, Chan SF, Lo MW, Mak SK, et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007; 27: 531–6
   PubMed Web of Science ®Google Scholar
• Skoglund A, Sunzel B, Lerner UH. Comparison of three test methods used for the diagnosis of candidiasis. Scand J Dent Res 1994; 102: 295–8
   PubMedGoogle Scholar
• Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730–7
   PubMed Web of Science ®Google Scholar
• Suliman ME, Stenvinkel P, Barany P, Heimburger O, Anderstam B, Lindholm B. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. American J Kidney Dis 2003; 41(3 Suppl 1)S89–95
   PubMed Web of Science ®Google Scholar
• Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002; 113: 480–5
   PubMed Web of Science ®Google Scholar
• Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233: 542–8
   PubMed Web of Science ®Google Scholar
• Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997; 23: 317–25
   PubMed Web of Science ®Google Scholar
• Lamagni TL, Evans BG, Shigematsu M, Johnson EM. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990–9). Epidemiol Infect 2001; 126: 397–414
   PubMed Web of Science ®Google Scholar